When you’re looking to make changes to how clinical trials are run, it’s helpful to work with one of the top minds in the industry. By welcoming Robert Langer to its advisory board, that’s exactly what Lindus Health hopes to do.
Langer, an MIT professor and co-founder of Moderna, is the author of more than 1,500 scientific articles, holds hundreds of patents and has helped build an array of biotechnology firms.
Langer’s addition to the advisory board of contract research organization Lindus, which calls itself “the anti-CRO,” positions the company to address some of the most pressing challenges in clinical research. Langer’s mind for biotech business may also help the company experiment on the standard CRO model.
